Imipenem
Showing 26 - 50 of 146
COPD Exacerbation Acute Trial in H?i Phòng (Beta-Lactams, Fluoroquinolone)
Completed
- COPD Exacerbation Acute
-
Hải Phòng, VietnamHaiphong International Hospital
May 4, 2021
PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients
Unknown status
- Critical Illness
- Bacterial Infections
- Meropenem
- Imipenem
-
Hat Yai, Songkla, ThailandFaculty of Medicine, Prince of Songkla University, Thailand
Apr 28, 2020
Complicated Intra-abdominal Infection, Complicated Urinary Tract Infection Trial in Japan (Imipenem+Cilastatin/Relebactam)
Completed
- Complicated Intra-abdominal Infection
- Complicated Urinary Tract Infection
-
Nagoya, Aichi, Japan
- +28 more
Jan 20, 2021
Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)
Recruiting
- Pulmonary Disease Due to Mycobacteria (Diagnosis)
- Amikacin
- +13 more
-
South Brisbane, Queensland, Australia
- +36 more
Sep 12, 2022
Hospital-Acquired Bacterial Pneumonia, Ventilator-Associated Bacterial Pneumonia Trial in Worldwide (IMI/REL FDC, PIP/TAZ FDC,
Completed
- Hospital-Acquired Bacterial Pneumonia
- Ventilator-Associated Bacterial Pneumonia
- IMI/REL FDC
- +2 more
-
Belo Horizonte, Minas Gerais, Brazil
- +67 more
Jul 19, 2022
In Vitro Activity of Ceftolozane/Tazobactam and
Unknown status
- Ceftolozane/Tazobactam
- +2 more
- Ceftolozane/tazobactam
- imipenem- relebactam
-
Madrid, SpainHG Gregorio Marañón
Dec 10, 2019
Acinetobacter Baumannii-calcoaceticus Complex, Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia
Completed
- Acinetobacter Baumannii-calcoaceticus Complex
- +4 more
- ETX2514/Sulbactam + Imipenem/Cilastin
- Colistin + Imipenem/Cilastin
-
Chicago, Illinois
- +91 more
Aug 13, 2021
Urinary Tract Infections Trial in France (Temocillin, meropenem or imipenem)
Completed
- Urinary Tract Infections
- Temocillin
- meropenem or imipenem
-
Fort-de-france, Martinique, France
- +15 more
Apr 16, 2021
Urinary Tract Infections Trial (Cefiderocol, Imipenem/cilastatin)
Completed
- Urinary Tract Infections
- (no location specified)
Nov 20, 2019
Acute Pancreatitis Trial in Zagazig (diagnostic test, device, drug, combination product, dietary supplement, procedure)
Completed
- Acute Pancreatitis
- serum lipase or amylase
- +15 more
-
Zagazig, EgyptZagazig University Faculty of Human Medicine
Nov 3, 2020
Suspected or Documented Gram-negative Bacterial Infection Trial in Worldwide (IMI/REL, Active Control)
Recruiting
- Suspected or Documented Gram-negative Bacterial Infection
- IMI/REL
- Active Control
-
Tucson, Arizona
- +64 more
Aug 18, 2022
Intra-abdominal Infections Trial (Relebactam 250 mg, Relebactam 125 mg, Imipenem/cilastatin)
Completed
- Intra-abdominal Infections
- Relebactam 250 mg
- +3 more
- (no location specified)
Jun 7, 2019
Carbapenem-Resistant Enterobacteriaceae Infection Trial in China (treatment with or without colistin)
Not yet recruiting
- Carbapenem-Resistant Enterobacteriaceae Infection
- treatment with or without colistin
-
Hefei, Anhui, China
- +13 more
Sep 20, 2023
DetectAB - Detecting Antibiotics
Completed
- Antibiotic Drug Concentration in Sweat
- analysis of last resort antibiotic drug (Flucloxacillin, Imipenem, Vancomycin or Cefepim) in sweat and blood
-
Basel, SwitzerlandUniversity Hospital Basel
Dec 10, 2019
Urinary Tract Infections, Pyelonephritis Trial (Relebactam 250 mg, Relebactam 125 mg, imipenem/cilastatin 500 mg)
Completed
- Urinary Tract Infections
- Pyelonephritis
- Relebactam 250 mg
- +4 more
- (no location specified)
Apr 26, 2019
Osteomyelitis Trial in Louisville (oral antibiotics, intravenous antibiotics)
Terminated
- Osteomyelitis
- oral antibiotics
- intravenous antibiotics
-
Louisville, KentuckyUniversity of Louisville
Apr 2, 2021
Febrile Neutropenia, Hematological Malignancy Trial in Amsterdam, The Hague (Discontinuation of imipenem-cilastatin or
Completed
- Febrile Neutropenia
- Hematological Malignancy
- Discontinuation of imipenem-cilastatin or meropenem
-
Amsterdam, Netherlands
- +1 more
Sep 23, 2019
Suspected or Documented Gram-negative Bacterial Infection Trial in Worldwide (IMI/REL FDC)
Completed
- Suspected or Documented Gram-negative Bacterial Infection
- IMI/REL FDC
-
Little Rock, Arkansas
- +32 more
Oct 28, 2021
Infection Trial in Chicago (Ciprofloxacin, trimethoprim-sulfamethoxazole, cefuroxime)
Completed
- Infection
- Ciprofloxacin
- +7 more
-
Chicago, IllinoisNorthwestern University Department of Urology
Jun 6, 2019
Pneumonia, Ventilator-Associated, Pneumonia, Bacterial, Pneumonia Trial (Imipenem/cilastatin, Doripenem)
Completed
- Pneumonia, Ventilator-Associated
- +4 more
- (no location specified)
Mar 5, 2019
Critically Ill Patients With ECMO Trial in Hat Yai (Imipenem)
Unknown status
- Critically Ill Patients With ECMO
- Imipenem
-
Hat Yai, Songkla, ThailandDivision of Clinical Pharmacology, Department of Medicine, Facul
Feb 13, 2019
Colonization or Infection With Carbapenem-Resistant
Recruiting
- Carbapenem-Resistant Enterobacteriaceae Infection
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Jan 11, 2023
Community-Acquired Pneumonia, Antimicrobial Stewardship, Point-of-Care Testing Trial in United States (Rapid Diagnostic Testing,
Recruiting
- Community-Acquired Pneumonia
- +2 more
- Rapid Diagnostic Testing
- Pharmacist-led de-escalation
-
Weston, Florida
- +10 more
Jan 5, 2023